Definitive Healthcare Corp. (NASDAQ:DH) Given Consensus Recommendation of “Hold” by Analysts

Definitive Healthcare Corp. (NASDAQ:DH) has received a consensus rating of “Hold” from the eleven ratings firms that are covering the stock, MarketBeat reports. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the company. The average twelve-month price target among analysts that have covered the stock in the last year is $5.81.

A number of brokerages have recently weighed in on DH. Barclays cut their price objective on Definitive Healthcare from $6.00 to $4.00 and set an “equal weight” rating on the stock in a research report on Wednesday, August 7th. BTIG Research initiated coverage on Definitive Healthcare in a research note on Tuesday. They set a “buy” rating and a $7.00 price objective for the company. Robert W. Baird reduced their target price on Definitive Healthcare from $6.00 to $5.00 and set a “neutral” rating for the company in a report on Wednesday, August 7th. Needham & Company LLC reissued a “hold” rating on shares of Definitive Healthcare in a report on Tuesday, August 6th. Finally, JPMorgan Chase & Co. lowered Definitive Healthcare from a “neutral” rating to an “underweight” rating and reduced their target price for the stock from $7.00 to $5.00 in a report on Wednesday, July 31st.

Definitive Healthcare Stock Up 5.5 %

Shares of NASDAQ DH opened at $4.81 on Friday. The business’s fifty day moving average price is $4.63 and its 200-day moving average price is $5.90. The stock has a market capitalization of $567.27 million, a PE ratio of -2.75, a P/E/G ratio of 6.38 and a beta of 1.33. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.40 and a quick ratio of 2.40. Definitive Healthcare has a one year low of $3.19 and a one year high of $10.62.

Definitive Healthcare (NASDAQ:DH) last released its quarterly earnings results on Monday, August 5th. The company reported $0.09 earnings per share for the quarter, meeting the consensus estimate of $0.09. The firm had revenue of $63.70 million for the quarter, compared to analysts’ expectations of $63.19 million. Definitive Healthcare had a positive return on equity of 0.98% and a negative net margin of 156.65%. The company’s revenue was up 4.4% compared to the same quarter last year. During the same quarter last year, the firm posted $0.08 EPS. On average, equities research analysts anticipate that Definitive Healthcare will post 0.07 EPS for the current year.

Hedge Funds Weigh In On Definitive Healthcare

A number of institutional investors and hedge funds have recently modified their holdings of DH. Norden Group LLC bought a new position in shares of Definitive Healthcare during the first quarter valued at approximately $83,000. Susquehanna Fundamental Investments LLC purchased a new stake in shares of Definitive Healthcare during the first quarter valued at $120,000. Sanctuary Advisors LLC bought a new stake in Definitive Healthcare during the 2nd quarter valued at about $85,000. Canada Pension Plan Investment Board purchased a new stake in Definitive Healthcare in the 2nd quarter valued at about $109,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its stake in Definitive Healthcare by 31.4% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 21,292 shares of the company’s stock worth $116,000 after acquiring an additional 5,083 shares in the last quarter. Hedge funds and other institutional investors own 98.67% of the company’s stock.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.